What is the proper dosing and administration schedule for mirtazapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Take Mirtazapine

Start mirtazapine at 15 mg once daily, taken in the evening before bedtime, and increase to 30-45 mg daily if needed after 1-2 weeks based on response. 1

Starting Dose and Timing

  • Initial dose: 15 mg once daily 1
  • Take in the evening, preferably at bedtime 1
  • This timing leverages mirtazapine's sedating properties to help with sleep while minimizing daytime drowsiness 2

Dose Titration

If inadequate response after 1-2 weeks:

  • Increase to 30 mg daily 1
  • Can further increase to maximum 45 mg daily if needed 1
  • Wait at least 1-2 weeks between dose changes to allow adequate time to assess response 1

The evidence supports that increasing from 15 mg to 30 mg in early non-responders (those without ≥20% symptom improvement at week 1) leads to significantly better outcomes 3. However, increasing beyond 30 mg to 45 mg shows less clear benefit 3.

Special Dosing Considerations

Dose reductions may be needed for:

  • Elderly patients: Start lower due to 40% reduced clearance in elderly males and 10% in elderly females 1
  • Renal impairment: 30% reduction in clearance (GFR 11-39) or 50% reduction (GFR <10) 1
  • Hepatic impairment: 30% reduction in clearance 1
  • Obesity (BMI ≥28): Consider 22.5-30 mg/day (29% reduced clearance) 4

Drug interactions requiring dose adjustment:

  • With paroxetine: Reduce to 22.5-30 mg/day (27% reduced clearance) 4
  • With fluvoxamine: Reduce to 15 mg/day (51% reduced clearance) 4
  • With cimetidine: Decrease dose (>50% increase in mirtazapine levels) 1
  • With strong CYP3A4 inhibitors (ketoconazole, clarithromycin): Decrease dose 1
  • With strong CYP3A4 inducers (carbamazepine, phenytoin, rifampin): May need dose increase (approximately 2-fold increase in clearance) 1

Administration Guidelines

  • Can be taken with or without food (minimal effect on absorption) 1
  • Swallow tablets whole
  • Do not stop abruptly - taper gradually to avoid withdrawal symptoms 1
  • Steady-state levels achieved within 5 days 1
  • Peak plasma levels occur approximately 2 hours after dosing 1

Important Safety Precautions

Do NOT take mirtazapine if:

  • Currently taking or stopped an MAOI within the past 14 days 1
  • Wait at least 14 days after stopping mirtazapine before starting an MAOI 1

Screen for bipolar disorder before starting - mirtazapine can trigger manic episodes in susceptible individuals 1

Common Side Effects to Anticipate

  • Increased appetite and weight gain (particularly relevant at lower doses) 5, 1
  • Sedation/drowsiness (paradoxically more common at 15 mg than higher doses) 5, 1
  • Constipation or diarrhea 5
  • Dry mouth 6

Serious but rare side effects requiring immediate medical attention:

  • Fever, sore throat, flu-like symptoms (possible low white blood cell count) 1
  • Signs of serotonin syndrome when combined with other serotonergic drugs 1

Clinical Context by Indication

For depression: The standard approach outlined above applies 1

For insomnia in palliative care: Mirtazapine is especially effective when depression and anorexia coexist 7

For gastroparesis/functional GI disorders: Start at 7.5-30 mg/day 8, with guidelines suggesting 15 mg once daily as the starting dose with titration to maximum 45 mg/day 5

For IBS with abdominal pain: 15 mg once daily starting dose, titrating to 45 mg maximum 5, 9

The evidence consistently supports evening dosing to maximize sleep benefits while therapeutic effects on mood, appetite, and pain develop over 1-2 weeks of treatment.

Related Questions

What is the recommended starting dose, titration schedule, contraindications, side effects, and monitoring for mirtazapine in an adult with major depressive disorder, especially when insomnia is a primary symptom?
Can mirtazapine be tapered from 30 mg to 15 mg as part of a taper schedule?
When is mirtazapine 30 mg preferred over mirtazapine 15 mg, and what are the considerations?
How soon after initiating mirtazapine does sedation typically occur?
How should mirtazapine be dosed, administered, monitored, and tapered, and what are its contraindications and side effects?
What is the preferred oral treatment regimen for a geriatric resident in a long-term skilled nursing facility with community-acquired pneumonia, chronic obstructive pulmonary disease (COPD) on chronic oxygen therapy, and no signs of systemic illness?
What is the interpretation of a total estradiol of 96 pg/mL, follicle‑stimulating hormone (FSH) of 10.5 mIU/mL, and luteinizing hormone (LH) of 10.7 mIU/mL in a reproductive‑age woman?
What treatment recommendations should be given for a nursing home resident with a chest X‑ray negative for pneumonia who has had desaturations requiring increased supplemental oxygen, cough, congestion, and episodes of apnea but no fever or chills?
What is Paxil (paroxetine) and what are its indications, dosing, contraindications, and common side effects?
What hemodynamic profile characterizes heart failure with preserved ejection fraction (HFpEF) and diastolic dysfunction?
What is the recommended dosing of Augmentin (amoxicillin‑clavulanate) for an uncomplicated lower respiratory tract infection in an adult without beta‑lactam allergy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.